Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 223

1.

Genetic variation in the first-pass metabolism of ethinylestradiol, sex hormone binding globulin levels and venous thrombosis risk.

Stegeman BH, Vos HL, Helmerhorst FM, Rosendaal FR, Reitsma PH, van Hylckama Vlieg A.

Eur J Intern Med. 2017 Jul;42:54-60. doi: 10.1016/j.ejim.2017.05.019. Epub 2017 Jun 1.

PMID:
28579309
2.

Human Extravillous Trophoblasts Penetrate Decidual Veins and Lymphatics before Remodeling Spiral Arteries during Early Pregnancy.

He N, van Iperen L, de Jong D, Szuhai K, Helmerhorst FM, van der Westerlaken LA, Chuva de Sousa Lopes SM.

PLoS One. 2017 Jan 12;12(1):e0169849. doi: 10.1371/journal.pone.0169849. eCollection 2017.

3.

Gonadotropin-releasing hormone agonist against severe aggression in autism.

van der Weiden RM, Helmerhorst FM, Eriksson T.

BMJ Case Rep. 2016 Sep 21;2016. pii: bcr2016216378. doi: 10.1136/bcr-2016-216378.

PMID:
27655876
4.

Progestin-only contraceptives: effects on weight.

Lopez LM, Ramesh S, Chen M, Edelman A, Otterness C, Trussell J, Helmerhorst FM.

Cochrane Database Syst Rev. 2016 Aug 28;(8):CD008815. doi: 10.1002/14651858.CD008815.pub4. Review.

5.

Hormonal contraceptives for contraception in overweight or obese women.

Lopez LM, Bernholc A, Chen M, Grey TW, Otterness C, Westhoff C, Edelman A, Helmerhorst FM.

Cochrane Database Syst Rev. 2016 Aug 18;(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Review.

PMID:
27537097
6.

Assisted reproductive technology and pregnancy outcomes.

Helmerhorst FM, Keirse M.

BJOG. 2016 Jul;123(8):1329. doi: 10.1111/1471-0528.13813. Epub 2015 Dec 10. No abstract available.

7.

Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.

Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM.

Cochrane Database Syst Rev. 2015 Aug 27;(8):CD011054. doi: 10.1002/14651858.CD011054.pub2. Review.

PMID:
26310586
8.

Steroidal contraceptives and bone fractures in women: evidence from observational studies.

Lopez LM, Chen M, Mullins Long S, Curtis KM, Helmerhorst FM.

Cochrane Database Syst Rev. 2015 Jul 21;(7):CD009849. doi: 10.1002/14651858.CD009849.pub3. Review.

PMID:
26195091
9.

Melanoma risk after ovarian stimulation for in vitro fertilization.

Spaan M, van den Belt-Dusebout AW, Schaapveld M, Mooij TM, Burger CW, van Leeuwen FE; OMEGA-project group.

Hum Reprod. 2015 May;30(5):1216-28. doi: 10.1093/humrep/dev023. Epub 2015 Mar 4.

PMID:
25743782
10.

Development of the follicular basement membrane during human gametogenesis and early folliculogenesis.

Heeren AM, van Iperen L, Klootwijk DB, de Melo Bernardo A, Roost MS, Gomes Fernandes MM, Louwe LA, Hilders CG, Helmerhorst FM, van der Westerlaken LA, Chuva de Sousa Lopes SM.

BMC Dev Biol. 2015 Jan 21;15:4. doi: 10.1186/s12861-015-0054-0.

11.

The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency.

Voorhuis M, Onland-Moret NC, Janse F, Ploos van Amstel HK, Goverde AJ, Lambalk CB, Laven JS, van der Schouw YT, Broekmans FJ, Fauser BC; Dutch Primary Ovarian Insufficiency Consortium.

Hum Reprod. 2014 Jul;29(7):1585-93. doi: 10.1093/humrep/deu095. Epub 2014 May 7.

PMID:
24812319
12.

Combined oral contraceptives: venous thrombosis.

de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM.

Cochrane Database Syst Rev. 2014 Mar 3;(3):CD010813. doi: 10.1002/14651858.CD010813.pub2. Review.

PMID:
24590565
13.

Not only randomised controlled trials, but also controlled observational studies.

Helmerhorst FM.

Eur J Contracept Reprod Health Care. 2014 Feb;19(1):71. doi: 10.3109/13625187.2013.871251. No abstract available.

PMID:
24484049
14.

Combination contraceptives: effects on weight.

Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM.

Cochrane Database Syst Rev. 2014 Jan 29;(1):CD003987. doi: 10.1002/14651858.CD003987.pub5. Review.

PMID:
24477630
15.

Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives.

Raps M, Curvers J, Helmerhorst FM, Ballieux BE, Rosing J, Thomassen S, Rosendaal FR, van Vliet HA.

Thromb Res. 2014 Apr;133(4):640-4. doi: 10.1016/j.thromres.2013.12.041. Epub 2014 Jan 7.

PMID:
24438944
16.

The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors.

Roach RE, Lijfering WM, van Hylckama Vlieg A, Helmerhorst FM, Rosendaal FR, Cannegieter SC.

Blood. 2013 Dec 19;122(26):4264-9. doi: 10.1182/blood-2013-07-518159. Epub 2013 Nov 1.

17.

Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis.

Stegeman BH, de Bastos M, Rosendaal FR, van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM.

BMJ. 2013 Sep 12;347:f5298. doi: 10.1136/bmj.f5298. Review.

18.

Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.

Buis CC, van Leeuwen FE, Mooij TM, Burger CW; OMEGA Project Group.

Hum Reprod. 2013 Dec;28(12):3358-69. doi: 10.1093/humrep/det340. Epub 2013 Sep 5.

PMID:
24014607
19.

Progestin-only contraceptives: effects on weight.

Lopez LM, Edelman A, Chen M, Otterness C, Trussell J, Helmerhorst FM.

Cochrane Database Syst Rev. 2013 Jul 2;(7):CD008815. doi: 10.1002/14651858.CD008815.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD008815.

20.

Hormonal contraceptives for contraception in overweight or obese women.

Lopez LM, Grimes DA, Chen M, Otterness C, Westhoff C, Edelman A, Helmerhorst FM.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008452. doi: 10.1002/14651858.CD008452.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD008452.

PMID:
23633356

Supplemental Content

Loading ...
Support Center